Australia markets closed

Jack Nathan Medical Corp. (JNHMF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.05100.0000 (0.00%)
At close: 01:26PM EST
Full screen
Trade prices are not sourced from all markets
Previous close0.0510
Open0.0364
BidN/A x N/A
AskN/A x N/A
Day's range0.0510 - 0.0510
52-week range0.0310 - 0.0900
Volume100
Avg. volume440
Market cap4.446M
Beta (5Y monthly)-1.85
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Jack Nathan Health Announces Its Q3 Fiscal 2024 Financial Results

    TORONTO, December 12, 2023--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") announced today its unaudited interim consolidated financial results for the third quarter of fiscal 2024, nine months ended October 31, 2023. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS").

  • Business Wire

    Jack Nathan Health Mexico to Open its First Flagship Medical Center in Mexico

    MEXICO CITY, October 03, 2023--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") is pleased to announce that its Mexican subsidiary, Jack Nathan Health Mexico, started operations of its first medical center in Mexico city, Mexico. This state-of-the-art facility will provide a wide range of comprehensive healthcare services, including: general medicine, internal medicine, pediatrics, laboratory services, nutrition counseling, psychology, ultrasound

  • Business Wire

    Jack Nathan Health Announces Its Q2 Fiscal 2024 Financial Results

    TORONTO, September 21, 2023--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") announced today its unaudited interim consolidated financial results for the second quarter of fiscal 2024, six months ended July 31, 2023. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS").